BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 25645281)

  • 21. The Prion 2018 round tables (II): Aβ, tau, α-synuclein… are they prions, prion-like proteins, or what?
    Eraña H
    Prion; 2019 Jan; 13(1):41-45. PubMed ID: 30646820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prion-like propagation of α-synuclein in neurodegenerative diseases.
    Tarutani A; Hasegawa M
    Prog Mol Biol Transl Sci; 2019; 168():323-348. PubMed ID: 31699325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copper brain homeostasis: role of amyloid precursor protein and prion protein.
    Inestrosa NC; Cerpa W; Varela-Nallar L
    IUBMB Life; 2005 Sep; 57(9):645-50. PubMed ID: 16203684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Amyloidgenesis in prion disease].
    Tsuboi Y
    Brain Nerve; 2014 Jul; 66(7):849-55. PubMed ID: 24998829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein folding and aggregation: two sides of the same coin in the condensation of proteins revealed by pressure studies.
    Silva JL; Cordeiro Y; Foguel D
    Biochim Biophys Acta; 2006 Mar; 1764(3):443-51. PubMed ID: 16480935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pressure-temperature folding landscape in proteins involved in neurodegenerative diseases and cancer.
    Cordeiro Y; Foguel D; Silva JL
    Biophys Chem; 2013 Dec; 183():9-18. PubMed ID: 23849959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular vesicles--Their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases.
    Coleman BM; Hill AF
    Semin Cell Dev Biol; 2015 Apr; 40():89-96. PubMed ID: 25704308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.
    Jucker M; Walker LC
    Nature; 2013 Sep; 501(7465):45-51. PubMed ID: 24005412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
    Victoria GS; Zurzolo C
    J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prions and Non-infectious Amyloids of Mammals - Similarities and Differences.
    Galkin AP; Velizhanina ME; Sopova YV; Shenfeld AA; Zadorsky SP
    Biochemistry (Mosc); 2018 Oct; 83(10):1184-1195. PubMed ID: 30472956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metals ions and neurodegeneration.
    Molina-Holgado F; Hider RC; Gaeta A; Williams R; Francis P
    Biometals; 2007 Jun; 20(3-4):639-54. PubMed ID: 17294125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propagation of prions causing synucleinopathies in cultured cells.
    Woerman AL; Stöhr J; Aoyagi A; Rampersaud R; Krejciova Z; Watts JC; Ohyama T; Patel S; Widjaja K; Oehler A; Sanders DW; Diamond MI; Seeley WW; Middleton LT; Gentleman SM; Mordes DA; Südhof TC; Giles K; Prusiner SB
    Proc Natl Acad Sci U S A; 2015 Sep; 112(35):E4949-58. PubMed ID: 26286986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical review of the prion hypothesis of human synucleinopathies.
    Tamgüney G; Korczyn AD
    Cell Tissue Res; 2018 Jul; 373(1):213-220. PubMed ID: 29116402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prion, prionoids and infectious amyloid.
    Liberski PP
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S80-4. PubMed ID: 24262195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decoding the Cellular Trafficking of Prion-like Proteins in Neurodegenerative Diseases.
    Hu C; Yan Y; Jin Y; Yang J; Xi Y; Zhong Z
    Neurosci Bull; 2024 Feb; 40(2):241-254. PubMed ID: 37755677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.
    Goedert M; Falcon B; Clavaguera F; Tolnay M
    Curr Neurol Neurosci Rep; 2014 Nov; 14(11):495. PubMed ID: 25218483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Could it be that neurodegenerative diseases are infectious?
    Derkinderen P
    Rev Neurol (Paris); 2019; 175(7-8):427-430. PubMed ID: 31358351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental inhibition of fibrillogenesis and neurotoxicity by amyloid-beta (Aβ) and other disease-related peptides/proteins by plant extracts and herbal compounds.
    Kumar S; Okello EJ; Harris JR
    Subcell Biochem; 2012; 65():295-326. PubMed ID: 23225009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The propagation of prion-like protein inclusions in neurodegenerative diseases.
    Goedert M; Clavaguera F; Tolnay M
    Trends Neurosci; 2010 Jul; 33(7):317-25. PubMed ID: 20493564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neurodegenerative amyloidoses: the yeast model].
    Vishnevskaia AB; Kushnirov VV; Ter-Avanesian MD
    Mol Biol (Mosk); 2007; 41(2):346-54. PubMed ID: 17514901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.